The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time.

For the full agenda, visit [ Ссылка ], and for information on the faculty, [ Ссылка ].

In this video, from the EGFR breakout session, Dr. Gainor discusses the management of uncommon EGFR mutations including EXON20.

A huge thank you to our sponsors! #AstraZeneca #Novartis #lilly #blueprintmedicines #takedaoncology #boehringerIngelheim #genentech

For more, please visit [ Ссылка ]. To join the conversation, visit [ Ссылка ].

свернуть